Revenue
$5.12M
Fiscal year ended 2026-06-30Operating income
-$34.20M
Fiscal year ended 2026-06-30Free cash flow
-$27.42M
Fiscal year ended 2026-06-30ASP Isotopes Inc. (ASPI) reported revenue of $5.12M and net income of -$33.99M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ASP Isotopes Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Miscellaneous Chemical Products.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.12M | $4.18M | $16.66M | $4.89M | $1.20M | $1.10M | $1.19M | $1.09M | $1.02M | $840.35K |
| Cost of revenue | $3.64M | $2.51M | $14.58M | $4.47M | $626.00K | $775.00K | $588.53K | $793.71K | $601.28K | $561.48K |
| Gross profit | $1.48M | $1.67M | $2.08M | $423.18K | $572.00K | $327.00K | $605.12K | $293.98K | $421.02K | $278.87K |
| Operating income | -$34.20M | -$24.89M | -$25.02M | -$14.97M | -$11.97M | -$7.95M | -$7.65M | -$5.43M | -$7.46M | -$5.81M |
| Net income | -$33.99M | -$7.12M | -$63.33M | -$12.89M | -$75.16M | -$8.46M | -$9.22M | -$7.36M | -$8.88M | -$6.96M |
| Research & development | $6.82M | $5.26M | $6.85M | $3.10M | $880.00K | $1.53M | $1.42M | $1.03M | $473.30K | $215.13K |
| Weighted-average diluted shares | shares 122.72M | shares 121.00M | shares 7.03M | shares 88.55M | shares 73.01M | shares 69.48M | shares 3.89M | shares 61.53M | shares 49.14M | shares 44.56M |
| Pretax income | -$34.09M | -$26.74M | -$63.15M | -$12.82M | -$75.06M | -$8.53M | -$9.07M | -$7.36M | -$8.87M | -$7.01M |
| Income tax expense | -$97.00K | -$31.00K | $183.85K | $73.63K | $95.00K | -$71.00K | $153.22K | -$8.37K | $13.77K | -$47.62K |
| Diluted EPS | $-0.27 | $-0.06 | $-0.84 | $-0.15 | $-1.03 | $-0.12 | $-0.13 | $-0.12 | $-0.24 | $-0.16 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $521.42K |
| General & administrative | $28.85M | $21.29M | $17.54M | $12.29M | $11.66M | $6.75M | $6.84M | $4.69M | $7.41M | $5.88M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $219.60M | $207.35M | $279.57M | $113.90M | $67.68M | $55.97M | $61.90M | $51.57M | Unavailable | Unavailable |
| Total assets | $572.05M | $587.67M | $498.02M | $225.89M | $135.91M | $90.87M | $94.35M | $84.13M | $54.76M | $45.39M |
| Current assets | $272.16M | $308.74M | $399.92M | $174.04M | $101.59M | $59.03M | $65.74M | $56.09M | $32.07M | $26.18M |
| Total liabilities | $297.26M | $288.65M | $235.12M | $129.29M | $107.60M | $45.15M | $43.18M | $42.11M | $40.40M | $32.36M |
| Current liabilities | $70.28M | $70.37M | $32.70M | $28.32M | $6.90M | $8.18M | $7.06M | $7.43M | $8.01M | $7.33M |
| Total equity incl. NCI | $274.79M | $299.02M | $262.90M | $96.60M | $28.31M | $45.73M | $51.17M | $42.01M | $14.36M | $13.03M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.53M | $1.37M | $1.10M | $1.37M | $1.05M | $342.69K | $66.00K | $84.85K | Unavailable | Unavailable |
| Accounts receivable | $3.04M | $2.39M | $1.08M | $17.43M | $649.48K | $692.24K | $707.00K | $560.43K | $515.45K | $354.08K |
| Goodwill | $6.47M | $6.39M | $5.18M | $6.85M | $3.36M | $3.26M | $3.17M | $3.46M | $3.29M | $3.29M |
| Long-term debt | $5.26M | $5.06M | $1.47M | $1.53M | Unavailable | Unavailable | $1.44M | Unavailable | Unavailable | Unavailable |
| Accounts payable | $5.70M | $6.87M | $3.81M | $3.42M | $2.60M | $2.05M | $1.02M | $1.80M | $2.43M | $2.22M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$23.33M | -$17.76M | -$17.85M | -$8.86M | -$7.90M | -$3.17M | -$3.76M | -$4.84M | -$5.12M | -$2.97M |
| Capital expenditures | $4.09M | $6.14M | $2.40M | $3.15M | $1.80M | $2.31M | $1.32M | $4.48M | $2.62M | $1.25M |
| Investing cash flow | $39.96M | -$97.18M | -$75.18M | -$1.50M | -$31.75M | -$2.36M | -$3.02M | -$4.48M | -$2.62M | -$1.25M |
| Financing cash flow | -$2.50M | $43.17M | $264.12M | $56.70M | $51.01M | -$225.00K | $17.69M | $32.43M | $12.15M | $20.26M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $4.54M | $4.41M | $5.22M | $4.48M | $4.43M | $1.89M | $2.26M | $2.07M | $2.52M | $1.71M |
| Common dividends paid | Unavailable | Unavailable | $0 | $0 | Unavailable | Unavailable | $341 | $0 | $2.78M | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $1.20M | $3.06M | $936.72K | $296.28K | $530.00K | $149.00K | $45.37K | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$27.42M | -$23.90M | -$20.25M | -$12.01M | -$9.70M | -$5.48M | -$5.08M | -$9.32M | -$7.75M | -$4.22M |
| Gross margin | 28.9% | 39.9% | 12.5% | 8.7% | 47.7% | 29.7% | 50.7% | 27.0% | 41.2% | 33.2% |
| Operating margin | -667.5% | -595.4% | -150.2% | -306.1% | -999.1% | -721.6% | -640.7% | -499.6% | -729.5% | -691.9% |
| FCF margin | -535.3% | -571.7% | -121.5% | -245.5% | -809.7% | -497.2% | -425.8% | -857.3% | -757.8% | -501.7% |
| SBC / revenue | 88.7% | 105.6% | 31.3% | 91.7% | 369.7% | 171.5% | 189.4% | 190.1% | 246.3% | 203.9% |
| Current ratio | 3.87x | 4.39x | 12.23x | 6.14x | 14.72x | 7.21x | 9.31x | 7.55x | 4.00x | 3.57x |
| Revenue YoY growth | 327.6% | 279.3% | 1295.7% | 349.5% | 17.2% | 31.1% | 175.7% | Unavailable | Unavailable | Unavailable |
| Net margin | -663.5% | -170.4% | -380.1% | -263.7% | -6273.5% | Unavailable | -772.5% | -676.2% | Unavailable | Unavailable |
| R&D / revenue | 133.2% | 125.9% | 41.1% | 63.4% | 73.5% | 138.8% | 118.6% | 95.1% | 46.3% | 25.6% |
| CapEx / revenue | 79.8% | 146.8% | 14.4% | 64.4% | 150.2% | 209.5% | 110.8% | 412.3% | 256.5% | 148.3% |
| Long-term debt / equity | 0.02x | Unavailable | 0.01x | 0.02x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ASPI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-20View SEC filing
10-K · Filed 2026-04-10View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-20View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.